TrialThe pharmacogenomics journal2018
The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro.
S Pillai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it